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trains. Results of antimicrobial synergy testing indicate that
lthough certain combinations may act synergistically, it was
till strain dependent. These preliminary ﬁndings require
urther conﬁrmation with testing of a larger number of iso-
ates. This study was funded by the University of Malaya
esearch Grant F vote: FS242/2008B
oi:10.1016/j.ijid.2010.02.1579
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PC Antibiogram in a large teaching Brazilian Hospital
. Almeida1, A.P. Cury2, M. Maffucci 2, H. Caiaffa2, J.A.
uarte2, F. Rossi 3,∗
University of São Paulo, São Paulo, São Paulo, Brazil
University of São Paulo, São Paulo, Brazil
HOSPITAL DAS CLINICAS, SAO PAULO, NA, Brazil
Background: Describe susceptibility proﬁle of KPC Kleb-
iella pneumoniae producers recovered in a teaching
ospital from São Paulo.
Methods: We analyzed 27 isolates of KPC, one per
atient, from July 2008 to April 2009. Identiﬁcation was per-
ormed by GNI650 Cards VitekTM (Biomerieux, Marcy l’Etoile,
rance); susceptibility test was performed by disk diffusion
nd the Hodge Test was done according to CLSI-M100S19
ecommendations. blaKPC detection was done by PCR with
reviously described primers and Pulsed Field Gel Elec-
rophoresis (PFGE) was also performed. Minimal Inhibitory
oncentration (MIC) for polymyxin B, tigecycline and car-
apenens was performed by EtestTM (Biomerieux, Marcy
’Etoile, France).
Results: KPC antibiogram showed multiple resistance as
xpected: 100% to ertapenem, 81,4% to meropenem, 77,7%
o imipenem, 93,6% to amikacin; 82,5% to gentamicin, 89%
o cefepime and ceftazidime and 100% to ciproﬂoxacin, sul-
hametoxazol/trimetropim, piperacillin/tazobactam and to
ztreonam. MIC 50/90 were 2mg/l and 3mg/l to tigecyclin,
nd 2mg/l and 48mg/l to polymyxin B. PFGE showed that
9% belonged to the same molecular proﬁle.
Conclusion: KPC isolates showed very few therapeutically
ptions being tygecyclin the most active drug among those
solates. In our institution treatment with polymyxin B alone
as to be carefully monitored until MIC is available. The
ame molecular proﬁle emphasizes the horizontal spreading
f these multiresistant bacteria.
oi:10.1016/j.ijid.2010.02.1580
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ecreased susceptibility to polymyxins emerging during
reatment for carbapenem-resistant Enterobacter aero-
enes infection
. Almeida1, H. Caiaffa1, A.P. Cury1, G.D. Almeida1, D.O.
arcia2, M.N. Burattini 1, F. Rossi 1,∗
University of São Paulo, São Paulo, Brazil
Instituto Adolfo Lutz, São Paulo, Brazil
Background: Emergence of carbapenem resistant enter-
bacteriaceae (CRE) is worrisome and polymyxins are
ossible therapeutic options. The objective of this article
o
w
h
pternational Congress on Infectious Diseases (ICID) Abstracts
s to describe emergency of polymyxins resistance during
herapy.
Methods: A 30 years old male patient with bilioma after
iver transplantation had eighteen successive cultures iso-
ates of E. aerogenes (Ea)from blood and peritoneum ﬂuid
ecovered during thirty days hospitalization. Identiﬁcation
as done by VitekTM (Biomerieux) and antimicrobial suscep-
ibility test were done by disk-diffusion (DD) and EtestTM (AB
iodisk) according to CLSI. Polymixins agar dilution was also
erformed. All isolates were submitted to pulsed ﬁeld gel
lectrophoresis analysis.
Results: In the third day of hospitalization the ﬁrst blood
ulture was positive for Ea susceptible to carbapenens. MIC
or polymyxin B was 1mg/L and for colistin 0,5mg/L. DD
howed 14mm of zone inhibition for colistin. After six days
f meropenem therapy Eaisolates became resistant to car-
apenens with MIC higher than 32mg/L. Colistin therapy
as initiated until patient’s death. The eight initials iso-
ates recovered before colistin treatment had MIC less than
g/ml for polymyxins and eight Ea isolates recovered after
his period had MIC above 12g/ml for polymyxins. The four-
eenth isolate, one day before the patient’s death, had MIC
f 64mg/L for polymyxin B and colistin, DD inhibition zone
or colistin was 7mm. Correlation between DD and MIC above
!g/ml for polymyxins was seen with disk inhibition zones
nferior than 13mm. All Ea belonged to the same clone.
Conclusion: CRE is a therapeutically and epidemiological
hallenge in every hospital. Colistin is one of the therapeu-
ically options but resistance may emerge during treatment
nd its in vitro activity is not routinely recommended by
LSI.
oi:10.1016/j.ijid.2010.02.1581
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utbreak of (OXA-66 carbapenemase) multidrug-resistant
cinetobacter baumannii in a Spanish tertiary-care hos-
ital: Epidemiology and study of patient movements
. Gonzalez ∗, E. Culebras, J. Head, M. Gomez, G. Morales,
. Picazo
Hospital Clinico San Carlos, Madrid, Spain
Background: Acinetobacter baumannii is an increasingly
ommon nosocomial pathogen. Carbapenems have been
he agents of choice for severe Acinetobacter infections.
e describe an outbreak of multidrug-resistant (MDR) A.
aumannii that produced OXA-66 carbapenemase and was
esistant to imipenem. We also analyze the relationship
etween the spread of this strain and patients’ movements
ithin the hospital.
Methods: Thirty-one isolates of A. baumannii with very
imilar susceptibility patterns from 15 patients, recovered
n a 2 months period, were studied. We analyzed 8 more
solates recovered during the following year. ERIC-PCR and
APD genotyping methods were used to deﬁne clusters of
lonally related isolates. PFGE was used to conﬁrm the
esults and to check the maintenance of the epidemic strain
ver the following year. Patterns of possible transmission
ere analyzed by recording patient movements within the
ospitals. Antibiotic susceptibility testing to 28 agents was
erformed by microdilution and by E-test. The isolates were
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screened by PCR analysis with primers speciﬁc for 6 car-
bapenemase genes. Ampliﬁcation products were sequenced
to determine the gene present.
Results: Twelve of the 15 patients studied were hospi-
talizated at the ICU. The most frequent sites of isolation
were the respiratory tract (16) and the blood (11). With the
exception of colistin (0% resistance) there were no antibi-
otics with good activity against these isolates. Of the other
antibiotics tested, tigecycline showed the best activity with
an MIC90 value of 2 mg/L. The genotypic study revealed
that the same strain was responsible for all the infections.
All the isolates harboured the bla-OXA-51—like gene and the
6 of them chosen to sequence the gene were identical and
100% homologous with the bla-OXA-66 gene. PCR showed
that the insertion sequence ISAba1 was present upstream of
the oxacillinase gene in all the isolates.
Conclusion: a) Molecular typing revealed that the out-
break detected in our hospital was due to a single A.
baumannii clonal group. b) The epidemic strain of A. bau-
mannii produces an OXA-66-ISAba1 carbapenem-hydrolyzing
oxacillinase. c) Even though the outbreak was controlled,
and the number of isolates decreased signiﬁcantly, the clone
responsible of the outbreak persisted at the hospital during
the following year.
doi:10.1016/j.ijid.2010.02.1582
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Online games teaching children hygiene and antibiotic
resistance: Evaluation of the e-Bug games
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McNulty2
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Background: e-Bug is a EC-funded antibiotic, hygiene
teaching resource aiming to reinforces an awareness of
microbes, respiratory hygiene and prudent antibiotics use
among junior and senior school children across Europe. e-
Bug junior web games were developed for children age 9-12
years. The e-Bug junior game has a number of ‘‘levels’’
teaching the given set of learning outcomes (LOs). Player,
shrunken inside human body, interacts with good and bad
cartoon microbes (Fig 1) as well as antibiotics and viruses.
Teaching the LOs is implemented through interaction with
microbes (making yogurt (Fig 3), ﬁnishing course of antibi-
otics (Fig 2). Knowledge is tested seamlessly before and after
each level in a Game Show style similar to the game ‘‘Do you
want to be a Millionaire?’’
Methods: Evaluation was primarily conducted in the UK
and online demonstrating statistically signiﬁcant knowledge
gain of the learning outcomes. This was complemented
by focus groups and observational studies with 29 pupils
taking part (and fully completing the pre and post question-
naire) from three schools. Before playing the game, only 4
pupils ‘‘agreed’’ that fungi were microbes while after play-
ing 18. Smaller improvements were seen in other questions
including: ‘‘We use microbes to make things like bread and
yogurt’’ (11 correct before, 23 correct after) and ‘‘Soap can
be used to wash away bad bugs’’ (20 before vs 24 after)
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Results: The main evaluation took place in May — August
009. Each of the completed levels was evaluated for sta-
istical signiﬁcance of knowledge change of the LOs. As
any questions were correct before and after the game, the
tatistically signiﬁcant improved responses were measured
using McNemar’s test), for the following questions: ‘‘if you
annot see a microbe it is not there’’, ‘‘most coughs and
olds get better without medicine’’ and in particular ‘‘we
se good microbes to make things like bread and yogurt’’.
here was a trend towards improved knowledge however in
ther questions did not reach statistic signiﬁcance
Conclusion: The study demonstrated that computer
ames can teach children about hygiene and antibiotics in
n enjoyable way. Further study is needed to evaluate an
mpact on behaviour change
oi:10.1016/j.ijid.2010.02.1583
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ntimicrobial utilization and susceptibility patterns of a
entinel group of bacterial isolates prior and subsequent
o the introduction of Ertapenem to the hospital formu-
ary
. Araujo1,∗, C. Rodrguez-Osorio1, E. Criollo-Mora1, A.
amos-Hinojosa1, A. Macías Hernandez2, A. Ponce-de-
eon1, J. Sifuentes-Osornio1
INSTITUTO NACIONAL DE CIENCIAS MEDICAS Y NUTRICION
ALVADOR ZUBIRAN, TLALPAN, Mexico
National Institute of Medical Sciences, Mexico City, Mexico
Background: It has been suggested that after the intro-
uction of ertapenem into hospital use, the amount of other
arbapenems and the rate of resistance to other antimi-
robials decreases. We conducted a retrospective study to
valuate these outcomes.
Methods: We studied 48 months (two 24 month-periods)
efore (PRE) and after (POST) the introduction of ertapenem
n August 2004. Antibiotic use was determined using the
tandard deﬁned daily dose (DDD) per 1000 patient/days.
ntimicrobial susceptibility testing to Escherichia coli,
seudomonas aeruginosa, Klebsiella pneumoniae and Acine-
obater baumanii was performed with the Vitek automated
ystem. We used chi-square for trend to compare rates of
esistance and changes in antimicrobial use.
Results: In the PRE-period, we analyzed 4072 E.
oli, 677 P. aeruginosa, 571K. pneumoniae, and 67 A.
aumanii isolates; in the POST 4648, 884, 559, and
09, respectively; antibiotic consumption was as follows:
RE-period: meropenem 89.9 DDD/1000/patients/days,
ntipseudomonal cephalosporins 90.9, and ceftriaxone
95.65; POST period: 75.3, 103.58, and 184.77, respec-
ively. The rate of antimicrobial susceptibility was: E. coli, to
eropenem in PRE-period 99.6% and in POST-period 98.05%,
o ceftazidime 88.67% and 84.75% (p < 0.000), respectively;
o P. aeruginosa, meropenem 67.41% and 61.74% (p = 0.004),
espectively, ceftazidime 63.74% and 62.12% (p = 0.3388),
espectively, and piperacillin/tazobactam 69.17% and
7.21%(p = 0.15), respectively; K. pneumoniae, meropenem
00% and 98.7% (p < 0.05), respectively, and ceftazidime,
6.60% and 90.29% (p = 0.018); A. baumanii, meropenem
5.2% and 79.09% (p = 0.08), respectively, and ceftazidime
6.14% and 58.88% (p = 0.12), respectively.
